EJGH is proud to introduce a powerful new solution for targeted biopsy of the prostate. The UroNav fusion biopsy system offers a cutting edge option for many patients with elevated and/or rising PSA levels.

Targeted MR/ultrasound biopsy is poised to become the new standard in prostate care, and EJGH is pleased to offer this powerful solution to our patients. UroNav fuses pre-biopsy MR images of the prostate with ultrasound-guided biopsy images in real time, for excellent delineation of the prostate and suspicious lesions.

The fusion of the MR and ultrasound images uses electromagnetic tracking, similar to your car’s GPS system; a tiny tracking sensor attached to the trans-rectal ultrasound probe generates a small, localized electromagnetic field that helps determine the location and orientation of the biopsy device. A sophisticated algorithm maintains the fusion of MR and ultrasound images, even when the patient moves.

For more information on prostate cancer detection, prevention, and treatment at EJGH, click here.